BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED

Beijing Tong Ren Tang Chinese Medicine Company Limited

3613

HK0000145638

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:07 05/06/2024 pm IST			5-day change	1st Jan Change
9.84 ^HKD	+1.97%		+1.65%	-18.95%

13/05	Tong Ren Tang Chinese Medicine Appoints CEO	MT
10/05	Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Wang Chi as an Executive Director and a Member of the Competition Executive Committee	CI

Beijing Tong Ren Tang Chinese Medicine Company Limited Proposes Special Interim Dividend, Payable on 21 October 2022

September 22, 2022 at 02:32 pm IST

Beijing Tong Ren Tang Chinese Medicine Company Limited announced Declaration and Payment of a Special Interim Dividend of HKD 0.25 per share. Ex-dividend date is 06 October 2022. Record date is 12 October 2022.

Payment date is 21 October 2022.

Latest news about Beijing Tong Ren Tang Chinese Medicine Company Limited

Tong Ren Tang Chinese Medicine Appoints CEO	13/05	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Wang Chi as an Executive Director and a Member of the Competition Executive Committee	10/05	CI
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces CEO Changes	10/05	CI
Beijing Tong Ren Tang Gets Nod to Sell Fever Drug in Hong Kong	30/04	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Announcement on Receiving the Certificate of Registration of Proprietary Chinese Medicine	30/04	CI
Beijing Tong Ren Tang Chinese Medicine CEO Steps Down; Acting CEO Appointed	29/03	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces CEO Changes	28/03	CI
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Resignation of Yu Jin as an Executive Director and Member of the Competition Executive Committee	28/03	CI
Beijing Tong Ren Tang Chinese Medicine's Profit Falls on Lower Revenue	15/03	MT
Beijing Tong Ren Tang Chinese Medicine Signs E-Commerce Framework Agreement	15/03	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 24 June 2024	14/03	CI
Beijing Tong Ren Tang Chinese Medicine Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	14/03	CI
Beijing Tong Ren Tang Flags Up to 22% Profit Drop in 2023	29/01	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023	29/01	CI
Beijing Tong Ren Tang Appoints Chairman	13/12	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Gu Hai Ou as Executive Director, Chairman of Board and Authorised Representative	13/12	CI
Beijing Tong Ren Tang to Vote Dec. 27 on Renewal of Distributorship Contracts	05/12	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Proposes New Exclusive Distributorship Framework Agreements	29/11	CI
Chinese listed firms used endangered animal parts as ingredients -report	23/23/23	RE
Three listed Chinese firms used endangered animal parts as ingredients- report	23/23/23	RE
Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Mr. Yu Jin as Executive Director and A Member of Competition Executive Committee	20/23/20	CI
Sinopharm CFO Retires; Successor Named	16/23/16	MT
Beijing Tong Ren Tang Chinese Medicine COO Resigns	13/23/13	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Resignation of Lin Man as Executive Director, Chief Operating Officer, Member of Competition Executive Committee	12/23/12	CI
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Retirement of Ding Yong Ling as Executive Director and Chairman of the Board	31/23/31	CI

Chart Beijing Tong Ren Tang Chinese Medicine Company Limited

Duration

Period

Chart Beijing Tong Ren Tang Chinese Medicine Company Limited

More charts

Company Profile

Beijing Tong Ren Tang Chinese Medicine Company Limited is a company mainly engaged in the manufacturing and sale of Chinese medicine. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. It is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.

Sector

Pharmaceuticals

Calendar

08/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Beijing Tong Ren Tang Chinese Medicine Company Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.84 HKD

Average target price

13.92 HKD

Spread / Average Target

+41.51%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED	-18.95%	1.03B
ELI LILLY AND COMPANY	+43.35%	750B
NOVO NORDISK A/S	+34.11%	606B
JOHNSON & JOHNSON	-6.75%	356B
MERCK & CO., INC.	+19.02%	326B
ABBVIE INC.	+7.01%	286B
ASTRAZENECA PLC	+18.08%	246B
ROCHE HOLDING AG	-3.44%	213B
NOVARTIS AG	+11.35%	213B
PFIZER, INC.	+1.98%	167B

Other Pharmaceuticals